SOBRE ESTE PODCAST 🔗

Apresentadores:
Frequência de atualização:
every 35 days
Duração média do áudio:
14 minutes
Entrevistas com convidados
Tem patrocinadores
Inglês
Estados Unidos da América
43 episódios
desde 15 de Janeiro de 2024
episodic

ÚLTIMO EPISÓDIO 🔗

When designing a trial for cutaneous lupus erythematosus (CLE), consider earlier primary endpoints, limited background therapy, and balanced racial representation to address placebo response. That’s just a few of the insights from the first-ever systematic review of placebo response in CLE trials, …

PESQUISAR EPISÓDIOS PASSADOS

Pesquisar episódios anteriores de Phase Forward.

EPISÓDIOS ANTERIORES

Warning: Do not attempt to set up a basket trial without a high level of operational expertise! However, if your CRO has that expertise, then the front-end complexities of a basket trial will yield rich downstream efficiencies (like saving 6+ months on a study!) It’s all about system setup, getting…
PMR, lupus, and emerging MOAs... Oh my! So much innovation at this month's mammoth rheumatology scientific congress, EULAR - the European Alliance of Associations for Rheumatology, in London, England. Join us in conversation with Ekaterina Radchenko, Senior Project Manager at Indero, who is exper…
In this episode, Global Head of Clinical Trial Delivery Diane Leclerc explores how ground‑level insight shapes strategy, accelerates decisions, and strengthens team accountability. She unpacks practical ways organizations can empower operational teams to influence direction, innovate, and adapt dur…
In this episode, Esther Sanchez, Associate Director of the Global Start-Up Unit at Indero, shares insights from her 24+ years in clinical research. She breaks down why a strong startup unit is critical to clinical trial success, how resilient “front‑line” teams protect timelines, and the essential …
In this episode of Phase Forward, Raelle Kennedy Brown—brand marketing consultant, patient advocate, and founder of Woke Within (Skin), shares how storytelling can transform patient advocacy. We discuss building trust in clinical trials, designing research that reflects diversity, and addressing th…
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sam…
In this episode of Phase Forward, Siow Bee Seu, Director of Clinical Operations for APAC at Indero, shares her perspective on the evolving clinical trial landscape across the APAC region. With nearly 2 decades of experience in clinical research, she offers valuable insights into the strategic impor…
In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promo…
In this episode, Isabel Dorion, Senior Director of Clinical Operations at Indero, shares expert insights on the critical role of Clinical Research Associates (CRAs) in ensuring trial quality and patient safety. Explore key strategies for effective CRA oversight and discover how quality reviews and …
Aviso: O podcast e a arte incorporada nesta página são de Phase Forward, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.